Skip to main content

Table 1 A summary of NICE (National Institute for Health and Care Excellence) guidelines for anti-VEGF treatment in Wet AMD

From: Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study

Indication

• Wet AMD

Clinical and imaging features

• Best-corrected visual acuity between 6/12 and 6/96

• Evidence of disease activity

• Absence of permanent structural damage to the central fovea

• Lesion size ≤ 12 disc areas